Henan Lingrui Pharmaceutial Co., Ltd.SSE: 600285

Announcement on Results of Shareholding Reduction by Director

· Issued by Henan Lingrui Pharmaceutial Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · · 3 pages · Chinese

Summary by 6ix AI

Henan Lingrui Pharmaceutical Co., Ltd. has announced the results of a shareholding reduction by a director. The director, Chen Yan, held a total of shares but did not execute any reduction during the specified period. The announcement confirms that the reduction plan was not implemented as planned, with no shares sold.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

Henan Lingrui Pharmaceutial Co., Ltd. on 6ix

Earlier from Henan Lingrui Pharmaceutial

Later from Henan Lingrui Pharmaceutial

All Henan Lingrui Pharmaceutial news releases